| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |